| Dr Javier Concepcion Salas-rivera, MD | |
|
Miramar Street 209, Bo. Guaniquilla, Parcelas Nueva, Aguada, PR 00602 | |
| (939) 969-4257 | |
| Not Available |
| Full Name | Dr Javier Concepcion Salas-rivera |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | Miramar Street 209, Aguada, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316141682 | NPI | - | NPPES |
| 14468 | Other | PR | MEDICAL LIC. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 14468 (Puerto Rico) | Primary |
| Entity Name | Integrate Community Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467674713 PECOS PAC ID: 6507760469 Enrollment ID: O20040209000113 |
News Archive
Being tall and overweight, or just being tall, might be a marker in children for an increased risk of being overweight or obese in later years.
Michael Traugott and the spin-off company Sinsoma GmbH, together with the Departments of Zoology and Microbiology at the University of Innsbruck, are developing a new PCR system for the detection of the SARS-CoV-2 virus.
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Although women have made strides in the business world, they still occupy less than two percent of CEO leadership positions in the Fortune 500. Not surprisingly therefore leaders still tend to be thought of as men and most industries are considered to be male-typed at management levels.
› Verified 6 days ago
| Entity Name | Aguada Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598057374 PECOS PAC ID: 0840462727 Enrollment ID: O20111019000410 |
News Archive
Being tall and overweight, or just being tall, might be a marker in children for an increased risk of being overweight or obese in later years.
Michael Traugott and the spin-off company Sinsoma GmbH, together with the Departments of Zoology and Microbiology at the University of Innsbruck, are developing a new PCR system for the detection of the SARS-CoV-2 virus.
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Although women have made strides in the business world, they still occupy less than two percent of CEO leadership positions in the Fortune 500. Not surprisingly therefore leaders still tend to be thought of as men and most industries are considered to be male-typed at management levels.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Javier Concepcion Salas-rivera, MD Road 2 126.4km, Aguadilla, PR 00605 Ph: (787) 882-2700 | Dr Javier Concepcion Salas-rivera, MD Miramar Street 209, Bo. Guaniquilla, Parcelas Nueva, Aguada, PR 00602 Ph: (939) 969-4257 |
News Archive
Being tall and overweight, or just being tall, might be a marker in children for an increased risk of being overweight or obese in later years.
Michael Traugott and the spin-off company Sinsoma GmbH, together with the Departments of Zoology and Microbiology at the University of Innsbruck, are developing a new PCR system for the detection of the SARS-CoV-2 virus.
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Although women have made strides in the business world, they still occupy less than two percent of CEO leadership positions in the Fortune 500. Not surprisingly therefore leaders still tend to be thought of as men and most industries are considered to be male-typed at management levels.
› Verified 6 days ago